Prolium Bioscience Raises $50M in Series A Funding, led by RTW Investments, to expand operations and R&D efforts.
Amount Raised
$50 Million
Round Type
Series A
CanadaBiotechnologyHealth CareTherapeuticsInvestors
Description
Prolium Bioscience, a NYC-based clinical stage biotechnology company, raised $50M in Series A funding. The round was led by RTW Investments (RTW). The company intends to use the funds to expand operations and its R&D efforts. Led by CEO Scott Requadt, Prolium Bioscience is developing a potential bispecific antibody for autoimmune diseases.
Quick answer
Prolium Bioscience raised $50 Million in a Series A round, dated March 5, 2026. Investors: RTW Investments. Prolium Bioscience is based in Canada.
- How much did Prolium Bioscience raise?
- Prolium Bioscience raised $50 Million in a Series A round on March 5, 2026.
- Who invested in Prolium Bioscience?
- RTW Investments is named as investors in this round.
- What does Prolium Bioscience do?
- Prolium Bioscience is a clinical stage biotechnology company developing PRO-203, a potential bispecific CD20xCD3 antibody for systemic sclerosis and other severe autoimmune diseases.
- Where is Prolium Bioscience based and how big is it?
- Prolium Bioscience is based in Canada.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Prolium Bioscience that raised within 45 days of this round, from Fundz verified event records.
- Beeline Medicines raised $300M (Series A) on April 16, 2026.
- STORM Therapeutics raised $56M (Series C) on April 16, 2026.
- Sparian Biosciences raised $15M (Grant) on April 13, 2026.
- Sidewinder Therapeutics raised $137M (Series B) on April 8, 2026.
- Marvel Biosciences raised an undisclosed amount (Funding Round) on April 7, 2026.
- TransCode Therapeutics raised $20M (Funding Round) on April 7, 2026.
Who to call at Prolium Bioscience, and when
A new round usually means Prolium Bioscience is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Prolium Bioscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Prolium Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Prolium Bioscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Prolium Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansProlium Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.